Poltreg S.A. (WSE:PTG)
Poland · Delayed Price · Currency is PLN 26.60
+1.40 (5.56%)
Dec 15, 2025, 4:32 PM CET
Poltreg Revenue
In the year 2024, Poltreg had annual revenue of 350.00K PLN, down -74.98%.
Revenue
350.00K
Revenue Growth
-74.98%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
117.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 350.00K | -1.05M | -74.98% |
| Dec 31, 2023 | 1.40M | 400.00K | 40.04% |
| Dec 31, 2022 | 999.00K | -100.00K | -9.10% |
| Dec 31, 2021 | 1.10M | 399.00K | 57.00% |
| Dec 31, 2020 | 700.00K | 200.00K | 40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |